Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets

被引:24
作者
Akiyoshi, DE [1 ]
Mor, S [1 ]
Tzipori, S [1 ]
机构
[1] Tufts Univ, Sch Vet Med, Dept Biomed Sci, Div Infect Dis, North Grafton, MA 01536 USA
关键词
D O I
10.1128/IAI.71.10.5765-5771.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genotypes 1 and 2 of Cryptosporidium parvum are the primary types associated with infections in humans, with type 1 being by far the predominant genotype. The frequency of mixed infection with both genotypes in humans is relatively rare, while type 1, which experimentally infects other mammals, has been found to naturally infect almost exclusively humans. One possible explanation for the absence of type 1 in other mammals and the low frequency of mixed infections in humans is the inability of type I to compete with type 2 in nature when both occur simultaneously. To investigate this, we challenged gnotobiotic piglets with equal number of oocysts of type 1 and type 2, given either simultaneously or with type 2 given 24 or 48 h after type 1. The genotype of the oocysts excreted in feces and the relative distribution of each of the genotypes throughout the gut at necropsy were determined. Regardless of the time interval between challenges with the two genotypes, type 2 invariably displaced type 1. The rate of displacement was rapid when both genotypes were given simultaneously, after which no traces of type 1 were detected in the feces or in gut sections by PCR. Infection with type 1 24 or 48 h before challenge with type 2, while permitting type 1 to become established, was still rapidly eliminated within 3 days after challenge with type 2. These observations have major implications regarding the relative perpetuation and survival of these two genotypes in mammals.
引用
收藏
页码:5765 / 5771
页数:7
相关论文
共 61 条
[51]   Cryptosporidium dose-response studies:: Variation between hosts [J].
Teunis, PFM ;
Chappell, CL ;
Okhuysen, PC .
RISK ANALYSIS, 2002, 22 (03) :475-485
[52]   Cryptosporidium dose response studies:: Variation between isolates [J].
Teunis, PFM ;
Chappell, CL ;
Okhuysen, PC .
RISK ANALYSIS, 2002, 22 (01) :175-183
[53]   Molecular analysis of Cryptosporidium species isolated from HIV-infected patients in Thailand [J].
Tiangtip, R ;
Jongwutiwes, S .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (04) :357-364
[54]  
TUMWINE JK, IN PRESS AM J TROP M
[55]   Natural history and biology of Cryptosporidium parvum [J].
Tzipori, S ;
Griffiths, JK .
ADVANCES IN PARASITOLOGY - OPPORTUNISTIC PROTOZOA IN HUMANS, 1998, 40 :5-36
[56]   Cryptosporidiosis: biology, pathogenesis and disease [J].
Tzipori, S ;
Ward, H .
MICROBES AND INFECTION, 2002, 4 (10) :1047-1058
[57]   EVALUATION OF AN ANIMAL-MODEL SYSTEM FOR CRYPTOSPORIDIOSIS - THERAPEUTIC EFFICACY OF PAROMOMYCIN AND HYPERIMMUNE BOVINE COLOSTRUM-IMMUNOGLOBULIN [J].
TZIPORI, S ;
RAND, W ;
GRIFFITHS, J ;
WIDMER, G ;
CRABB, J .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (04) :450-463
[58]   Genetic heterogeneity and PCR detection of Cryptosporidium parvum [J].
Widmer, G .
ADVANCES IN PARASITOLOGY - OPPORTUNISTIC PROTOZOA IN HUMANS, 1998, 40 :223-239
[59]   Animal propagation and genomic survey of a genotype 1 isolate of Cryptosporidium parvum [J].
Widmer, G ;
Akiyoshi, D ;
Buckholt, MA ;
Feng, X ;
Rich, SM ;
Deary, KM ;
Bowman, CA ;
Xu, P ;
Wang, Y ;
Wang, X ;
Buck, GA ;
Tzipori, S .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 108 (02) :187-197
[60]   Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru [J].
Xiao, LH ;
Bern, C ;
Limor, J ;
Sulaiman, I ;
Roberts, J ;
Checkley, W ;
Cabrera, L ;
Gilman, RH ;
Lal, AA .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03) :492-497